Placebo- and haloperidol-controlled double-blind trial of olanzapine in patients with manic or mixed episode of bipolar I disorder.

Trial Profile

Placebo- and haloperidol-controlled double-blind trial of olanzapine in patients with manic or mixed episode of bipolar I disorder.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2012

At a glance

  • Drugs Haloperidol; Olanzapine
  • Indications Bipolar disorders; Bipolar I disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2010 Results have been presented at the 27th International Congress of Collegium Internationale Neuro Psychopharmacologicum.
    • 23 Feb 2010 Actual patient number (224) added as reported by ClinicalTrials.gov.
    • 23 Feb 2010 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top